D

DOD Biotech PCL
SET:DOD

Watchlist Manager
DOD Biotech PCL
SET:DOD
Watchlist
Price: 1.62 THB -0.61% Market Closed
Market Cap: 729.7m THB

Operating Margin
DOD Biotech PCL

6.8%
Current
-19%
Average
5%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
6.8%
=
Operating Profit
42m
/
Revenue
617.4m

Operating Margin Across Competitors

No Stocks Found

DOD Biotech PCL
Glance View

Market Cap
729.7m THB
Industry
Consumer products

DOD Biotech Public Co., Ltd. is engaged in manufacture of food supplements. The company is headquartered in Samut Sakhon, Samut Sakhon. The company went IPO on 2018-06-20. The firm operates in five segments: supplementary business, manufacturing cosmetics, network marketing business, manufacturing extraction, and others. Its products categories include beauty products, which includes skincare products and dietary supplements; health products include health supplements, and own-branded products under brand Dieto, which is a protein food supplement, help maintain shape Helps reduce the accumulation of excess fat nervous system. The company offers tablet products, such as capsules and flower tablets. The firm provides drinking powder, such as Fiber Detox, which is a product with high fiber content, which helps in the digestive system. Its subsidiaries include DOD Healthy Life Co., Ltd., Ultima Life Co., Ltd., HY DOD Co., Ltd., and DOD Sale power Co., Ltd.

DOD Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
6.8%
=
Operating Profit
42m
/
Revenue
617.4m
What is the Operating Margin of DOD Biotech PCL?

Based on DOD Biotech PCL's most recent financial statements, the company has Operating Margin of 6.8%.

Back to Top